You can buy or sell BSX and other stocks, options, ETFs, and crypto commission-free!
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. Read More The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
52 Week High
52 Week Low
BRIEF-Boston Scientific Says Entered Into Second Amendment To $1 Billion 364-Day Term Loan Credit Agreement
May 29 (Reuters) - Boston Scientific Corp: * BOSTON SCIENTIFIC - ON MAY 28 ENTERED INTO SECOND AMENDMENT TO ITS $1 BILLION 364-DAY TERM LOAN CREDIT AGREEMENT
Boston Scientific Completes Approximately $2.0 Billion Aggregate Offerings of Common Stock and Mandatory Convertible Preferred Stock
MARLBOROUGH, Mass., May 27, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) completed the concurrent offerings of (i) 29,382,500 shares of its com
— per share
Expected Jul 22, Pre-Market